Chemotherapy for lymphatic filariasis: progress but not perfection

Melrose, Wayne D. (2003) Chemotherapy for lymphatic filariasis: progress but not perfection. Expert Review of Anti-infective Therapy, 1 (4). pp. 571-578.

[img] PDF (Published Version)
Restricted to Repository staff only

View at Publisher Website: http://dx.doi.org/10.1586/14787210.1.4.5...

Abstract

Currently, only three drugs are used to control and treat the mosquito-borne parasitic disease lymphatic filariasis: diethylcarbamazine, ivermectin (Mectizan®) and albendazole (Zentel®). All interrupt transmission by eliminating microfilaria, the parasite stage that is responsible for transmission between hosts, but do not reliably kill the adult worms that are responsible for much of the pathology seen in the disease. There is an urgent need to develop drugs that will reliably kill adult worms and several compounds are under-going in vitro and animal testing. An alternative strategy – that of targeting symbiont bacteria within the parasite – has also shown promising results.

Item ID: 6327
Item Type: Article (Refereed Research - C1)
Keywords: chemotherapy; lymphatic filariasis; albendazole; diethylcarbamazine; ivermectin; microfilaria
ISSN: 1744-8336
Date Deposited: 17 May 2010 01:07
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1108 Medical Microbiology > 110803 Medical Parasitology @ 100%
Citation Count from Scopus Scopus 8
Downloads: Total: 2
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page